Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Single cell and spatial transcriptomics studies of Fibrosis in Prospective Registry in IBD Study at MGH and GI Disease and Endoscopy Registry

ABSTRACT: Single cell and spatial transcriptomics studies of Fibrosis in Prospective Registry in IBD Study at MGH and GI Disease and Endoscopy Registry

PROVIDER: PRJNA1227598 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Single cell and spatial transcriptomics studies of Fibrosis in Prospective Registry in IBD Study at MGH and GI Disease and Endoscopy Registry

Project description:Single cell and spatial transcriptomics studies of Fibrosis in Prospective Registry in IBD Study at MGH and GI Disease and Endoscopy Registry

| PRJNA1227599 | ENA

RNA sequencing of CD11b+ cells isolated from human gut mucosal biopsies of IBD patients

Project description:CD11b+ cells isolated from IBD patient biopsies have distinct transcriptomic signatures based on their location along the GI tract, inflammation status, IBD type, and medication response. These cells also respond to JAK inhibitors by decreasing cytokine output.

2022-08-23 | GSE183620 | GEO

Sickle Cell Disease Implementation Consortium Registry (SCDIC Registry-BioLINCC)

Project description:Sickle Cell Disease Implementation Consortium Registry (SCDIC Registry-BioLINCC)

| PRJNA1300502 | ENA

Sickle Cell Disease Implementation Consortium Registry (SCDIC Registry-BioLINCC)

Project description:Sickle Cell Disease Implementation Consortium Registry (SCDIC Registry-BioLINCC)

| PRJNA1300503 | ENA

Expression analysis of Klebsiella pneumoniae MGH 78578 and capsule deletion mutant

2013-12-31 | GSE40011 | GEO

Expression analysis of Klebsiella pneumoniae MGH 78578 and capsule deletion mutant

Project description:To investigate the whole-genome gene expression difference between the wild-type and capsule deletion mutant in Klebsiella pneumoniae MGH 78578. The mutants analyzed in this study are further described in Huang T.W., Stapleton J.C., Chang H.Y., Tsai S.F., Palsson B.O., Charusanti P. Capsule removal via lambda-Red knockout system perturbs biofilm formation and fimbriae extression in Klesiella pneumoniae MGH 78578 (manuscript submission) A six chip study using total RNA recovered from three separate wild-type cultures and three separate cultures of a capsule deltion mutant of Klebsiella pneumoniae MGH 78578. The capsule gene cluster (KPN_02493 to KPN_02515) was entirely removed in the capsule deletion mutant. Each chip measures the expression level of 5,305 genes from Klebsiella pneumoniae MGH 78578 and the associated five plasmids (pKPN3, pKPN4, pKPN5, pKPN6 and pKPN7) with 50-mer oligo tiling array with 30-mer spacer.

2013-12-31 | E-GEOD-40011 | biostudies-arrayexpress

Next Generation Sequencing Quantitative Analysis of TEAD Palmitoylation Inhibitor MGH-CP1 in Breast Cancer Cell Line

Project description:Purpose: The goal of this study is to understand the signaling pathway alteration in cancer cell line treated with TEAD palmitoylation inhibitor MGH-CP1, and to further validate TEAD inhibitor for specifity in TEAD-YAP interuption. Methods:Breast cancer cell line MDA-MB-231 was chosen to be treated with TEAD palmitoylation inhibitor MGH-CP1 at 10μM for 24 hours. Total RNA was isolated for the analysis. RNA samples were sent to Novogen for library construction, RNA sequencing and raw data process. Results: MGH-CP1 specifically blocks TEAD transcriptional activity compared with YAP/TAZ siRNA in MDA-MB-231 cells. Conclusions: Our study privides gene expression profiling evidence to validate our TEAD palmitoylation inhibitor MGH-CP1 as specific small molecule to block TEAD transcriptional activity. We report the application of next generation sequencing technology for high-throughput profiling of TEAD palmitoylation inhibitor MGH-CP1 in breast cancer cells.

2021-05-11 | GSE140396 | GEO

Transcriptome analysis in acute GI GVHD reveals a unique signature in children and shared biology with pediatric IBD

Project description:We demonstrate a unique gene signature in acute GI GVHD with differential expression of genes which have been previously described as important in GVHD

2023-04-01 | GSE215068 | GEO

Gpr37 contributes to inflammation-induced GI dysmotility by regulating enteric reactive gliosis.

Project description:The enteric nervous system (ENS) is contained within two layers of the gut wall and is made up of neurons, immune cells, and enteric glia cells (EGCs) that regulate gastrointestinal (GI) function. EGCs in both inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) change in response to inflammation, referred to as reactive gliosis. Whether EGCs restricted to a specific layer or region within the GI tract alone can influence intestinal immune response is unknown. Using bulk RNA-sequencing and in situ hybridization, we identify G-protein coupled receptor, Gpr37, as a gene expressed only in EGCs of the myenteric plexus, one of the two layers of the ENS. We show that Gpr37 contributes to key components of LPS-induced reactive gliosis including activation of NF-kB and IFN-y signaling and response genes, lymphocyte recruitment, and inflammation-induced GI dysmotility. Targeting Gpr37 in EGCs presents a potential avenue for modifying inflammatory processes in the ENS.

2025-06-24 | GSE262418 | GEO

Breast Cancer Family Registry

Project description:Breast Cancer Family Registry

| PRJNA812673 | ENA